CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$31.15
-0.02 (-0.05%)
Performance
1D
—
1W
—
1M
—
3M
+27.40%
6M
+44.48%
1Y
+33.29%
YTD
+34.56%
Open$31.14
Previous Close$31.17
Day High$31.21
Day Low$31.13
52W High$32.56
52W Low$19.05
Volume—
Avg Volume3.78M
Market Cap3.81B
P/E Ratio17.79
EPS$1.68
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.76
Above
SMA 200
$22.30
Above
RSI (14)
48.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+60.9% upside
Current
$31.15
$31.15
Target
$50.13
$50.13
$36.48
$50.13 avg
$69.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 566.44M | 404.31M | 680.16M |
| Net Income | 206.12M | 132.41M | -27,885,830 |
| Profit Margin | 36.4% | 34.6% | -4.1% |
| EBITDA | 284.90M | 193.19M | -33,860,903 |
| Free Cash Flow | — | — | -33,852,425 |
| Rev Growth | +40.1% | +40.1% | +20.9% |
| Debt/Equity | — | — | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |